1. Home
  2. UXIN vs AQST Comparison

UXIN vs AQST Comparison

Compare UXIN & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uxin Limited ADS

UXIN

Uxin Limited ADS

HOLD

Current Price

$3.45

Market Cap

756.6M

ML Signal

HOLD

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$4.20

Market Cap

707.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UXIN
AQST
Founded
2011
2004
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
756.6M
707.6M
IPO Year
2018
2007

Fundamental Metrics

Financial Performance
Metric
UXIN
AQST
Price
$3.45
$4.20
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.83
AVG Volume (30 Days)
180.1K
4.3M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$67,430,000.00
Revenue This Year
$237.18
N/A
Revenue Next Year
$145.46
$11.33
P/E Ratio
$4.05
N/A
Revenue Growth
N/A
0.77
52 Week Low
$2.45
$2.20
52 Week High
$5.40
$7.55

Technical Indicators

Market Signals
Indicator
UXIN
AQST
Relative Strength Index (RSI) 50.95 54.33
Support Level $3.31 $3.69
Resistance Level $4.19 $4.44
Average True Range (ATR) 0.21 0.20
MACD 0.01 0.08
Stochastic Oscillator 34.23 95.97

Price Performance

Historical Comparison
UXIN
AQST

About UXIN Uxin Limited ADS

Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates used car e-commerce platforms through its mobile applications and websites. It facilitates used car transaction services and financing solutions offered by third-party financing partners to buyers for their used car purchases. The company generates revenue through sales of the commission of salvage car sales, and interest income from the financial lease. The Group generates its revenues in China, and assets of the company are also located in China Area.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: